Osaic Holdings’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Osaic Holdings's NVO Position: Q1 2026 in Review
Osaic Holdings increased its Novo Nordisk (NVO) stake by 14% in Q1 2026, buying an estimated $2.04M and bringing the position to 342,477 shares worth $12.6M. The position accounts for 0.02% of the portfolio, ranked #774.
Osaic Holdings first reported a position in NVO in Q1 2020 and has held it in 25 quarters since. The position peaked at $58.7M in Q3 2023. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Osaic Holdings held 342,477 shares of Novo Nordisk worth $12.6M as of Q1 2026.
- Osaic Holdings bought 43,148 Novo Nordisk shares in Q1 2026, an estimated $2.04M.
- Novo Nordisk made up 0.02% of Osaic Holdings's portfolio in Q1 2026, its #774 holding.
- Osaic Holdings first reported a position in Novo Nordisk in Q1 2020 and has held it in 25 quarters since.
- Osaic Holdings's Novo Nordisk position peaked at $58.7M in Q3 2023.
- 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.